Since 2016, the FDA has approved three disease-modifying treatments for spinal muscular atrophy, with several ...

Data from the SAPPHIRE study formed the basis of Scholar Rock's U.S. Food and Drug Administration request to approve ...

AlphaQuest LLC decreased its position in Scholar Rock Holding Co. (NASDAQ:SRRK – Free Report) by 97.4% in the fourth quarter, according to its most recent Form 13F filing with the SEC. The ...

The IMSD Community of Scholars Distinguished Seminar Series brings together ... and researchers to engage with cutting-edge topics spanning precision therapeutics, tumor suppressor pathways, ...

In a report released today, Marc Frahm from TD Cowen maintained a Buy rating on Incyte (INCY – Research Report), with a price target of $88.00.

UA Little Rock honored Emily Wells, the top graduate of 2024, celebrated Arkansas artist Kevin Kresse as the Distinguished Alumnus of the Year, as well as Libby Smith, the longtime award-winning ...

Shares of weight loss drug developers gained on Wednesday after Roche (OTCQX:RHHBF) announced a multi-billion-dollar deal ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

Trevi Therapeutics, Inc. (NASDAQ:TRVI – Get Free Report) shares reached a new 52-week high on Monday after HC Wainwright ...

Fulbright scholar Aubrey Lay was supposed to get paid for three months of work by the U.S. government through his teaching assistantship at a school for Ukrainian refugees in Estonia. Instead ...

Iron Paws, a new premium dog supplement brand, is proud to announce the launch of its veterinarian-formulated daily superfood powder, designed to support canine health and longevity. With a powerful ...